Aurobindo Pharma rises 2% on USFDA nod

Shares of Aurobindo Pharma rose as much as 2.18% in early morning trade after the company announced it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Ertapenem Injection 1 g/vial.

For Real Time News & Trading Trends Keep Liking Epic Research Private Limited

Facebook

Twitter

YouTube

Pinterest

Linkedin

Google+

Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300